FDA: Benefits Of Merck’s Gardasil Continue To Outweigh Risks

CNN Money

Augut 20, 2009

U.S. health authorities said Thursday the benefits of Merck & Co. Inc.’s (MRK) cervical-cancer vaccine Gardasil continue to outweigh its risks.

The joint statement from the Food and Drug Administration and Centers for Disease Control and Prevention followed this week’s publication of a safety analysis of Gardasil in the Journal of the American Medical Association. That analysis, conducted by FDA and CDC, found that girls and women who received the shot had higher rates of fainting and blood clots versus other vaccines, but that rates of other adverse events weren’t higher than expected.

“Based on the review of available information by FDA and CDC, Gardasil continues to be safe and effective, and its benefits continue to outweigh its risks,” the agencies said in a statement posted on the FDA Web site.

MORE…

Comment from Leslie

Interesting to find this in the money section at CNN – am sure it is to ward off worries of Merck investors…. So JAMA is pitted against FDA – Hmmm whom to believe?

PG

Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.